| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $601.9M | +23.0% |
| Cost of Revenue | $188.6M | +5.2% |
| Gross Profit | $413.3M | +33.3% |
| R&D Expense | $130.6M | -16.7% |
| SG&A Expense | $113.4M | -21.2% |
| Operating Income | -$94.8M | +70.3% |
| Pre-tax Income | -$65.9M | +78.4% |
| Income Tax | $1.7M | -8.4% |
| Net Income | -$50.3M | +76.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $693.6M | +27.5% |
| Accounts Receivable | $177.3M | +37.5% |
| Current Assets | $935.4M | +26.9% |
| Total Assets | $1.03B | +24.6% |
| Current Liabilities | $405.8M | +30.0% |
| Total Liabilities | $426.1M | +28.2% |
| Stockholders' Equity | $504.7M | +30.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $96.7M | +58.1% |
| Capital Expenditures | $1.0M | -60.2% |
| Investing Cash Flow | -$5.0M | +51.1% |
| Financing Cash Flow | $57.6M | -84.7% |
| Free Cash Flow | $95.6M | +63.4% |